Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Luther

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Journal of Clinical Pharmacology|May 11, 1999
Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability studyA A Taylor, R Mangoo-Karim, K D Ballard, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1992
Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a new renin inhibitor). I: Single dose studyS K Gupta, G R Granneman, R S Boger, et al.
Biochemical Pharmacology|April 1, 1989
Toxicity of uricosuric diuretics in rat hepatocyte cultureK G Tolman, P D Gray, S el Masry, et al.
The Journal of International Medical Research|January 1, 1986
Carteolol treatment of essential hypertension: a long-term study of safety and efficacyR R Luther, C J Maurath, M J Klepper, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996
Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic painS S Bowersox, T Gadbois, T Singh, et al.
American Heart Journal|April 1, 1989
The effects of terazosin and methyclothiazide on blood pressure and serum lipidsR R Luther, H N Glassman, C B Estep, et al.
Journal of Human Hypertension|April 1, 1990
Effects of terazosin on serum lipid levels in hypertensive blacksR R Luther, M J Klepper, C J Maurath, et al.
Journal of Human Hypertension|April 1, 1990
Efficacy of terazosin in the treatment of essential hypertension in blacksR R Luther, M J Klepper, C J Maurath, et al.
American Journal of Hypertension|July 1, 1988
Terazosin, a new selective alpha 1-adrenergic blocking agent. Results of long-term treatment in patients with essential hypertensionR R Luther, H N Glassman, C B Estep, et al.
Clinical Therapeutics|January 1, 1988
Effect of age on the pharmacokinetics of orally and intravenously administered terazosinL T Sennello, R C Sonders, H N Glassman, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pharmacology|May 11, 1999
Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability studyA A Taylor, R Mangoo-Karim, K D Ballard, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1992
Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a new renin inhibitor). I: Single dose studyS K Gupta, G R Granneman, R S Boger, et al.
Biochemical Pharmacology|April 1, 1989
Toxicity of uricosuric diuretics in rat hepatocyte cultureK G Tolman, P D Gray, S el Masry, et al.
The Journal of International Medical Research|January 1, 1986
Carteolol treatment of essential hypertension: a long-term study of safety and efficacyR R Luther, C J Maurath, M J Klepper, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996
Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic painS S Bowersox, T Gadbois, T Singh, et al.
American Heart Journal|April 1, 1989
The effects of terazosin and methyclothiazide on blood pressure and serum lipidsR R Luther, H N Glassman, C B Estep, et al.
Journal of Human Hypertension|April 1, 1990
Effects of terazosin on serum lipid levels in hypertensive blacksR R Luther, M J Klepper, C J Maurath, et al.
Journal of Human Hypertension|April 1, 1990
Efficacy of terazosin in the treatment of essential hypertension in blacksR R Luther, M J Klepper, C J Maurath, et al.
American Journal of Hypertension|July 1, 1988
Terazosin, a new selective alpha 1-adrenergic blocking agent. Results of long-term treatment in patients with essential hypertensionR R Luther, H N Glassman, C B Estep, et al.
Clinical Therapeutics|January 1, 1988
Effect of age on the pharmacokinetics of orally and intravenously administered terazosinL T Sennello, R C Sonders, H N Glassman, et al.
Pageof 5